Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
TEVA PHARMA (NEW ZEALAND) LIMITED,Fremanezumab,Chronic migraine prevention,Fremanezumab (Ajovy),Options for investment,Community and Hospital,Nervous System
